Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by alejo.g3ologiston May 02, 2019 10:47am
46 Views
Post# 29700543

RE:RE:penny the clown

RE:RE:penny the clown
brentkosta wrote:
alejo.g3ologist wrote: I think Penny knows the bid/ask thing he's just playing stupid here, his job is to annoy/entertein people by being contradictory...somebody has to be the clown anyways...let him be happy...please lets not argue with him anymore about this bid/ask thing...yes Penny you are right all the way...


You guys are arguing two differnt things. Penny is a fool, yes.... but hes arguing that ask VOLUME represents the demand in the stock. In which he is right. Remember, volume equals shares traded. 

The rest of you are arguing that shares STACKED on the ask are a represntation of weakness. This is correct. 

Penny is arguing bid/ask activity post-trade. You guys are offering bid/ask activity pre-trade. Thats all. 

In conclusion, you are both right. Bid equals demand. Ask equals supply. The ask VOLUME equates to the demand. If most volume was created on sell side, it would be a bearish signal. Basically were at a stale mate. People arent willing to slap the ask. Many people are sitting on a bid. And they slowly get filled as people sell into their bids. 

I cant believe I spent so much time with this post. I feel like Switzerland with my neutrality




In any case. I didn't slap the ask this time maybe i am selfish but got an order filled at 0.0425 of 440k more shares..totalling holding 1.34M shares...ill be swing trading the last added batch..dont see enough liquidity to swing trade on the warrants(A or B)...that's just my strategy for my cash flow..GL!
Bullboard Posts